Skip to content
Lower risk Medical device recall · FDA · Published October 19, 2026

Yeastone Broth Recall: False Antifungal Test Results Risk

Remel recalls Yeastone Broth (11ML, 10/BOX) used in clinical antifungal testing due to potential false susceptibility reports. Affected lots may cause incorrect antibiotic results.

🇺🇸 FDA recall #Z-0355-2027Medical deviceRemel ›
✎ GovInfoNow plain-language explainer

Remel is recalling Yeastone Broth used in clinical labs for antifungal testing because some batches might give false results. This could lead to incorrect antibiotic treatments for infections. Read more at govinfonow.com/recall/2255595-remel-inc-recalls-yeastone-broth-11ml-10-box-used-in.

Source Summary by GovInfoNow · govinfonow.com/recall/2255595-remel-inc-recalls-yeastone-broth-11ml-10-box-used-in · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #Z-0355-2027

Cite this page

“Yeastone Broth Recall: False Antifungal Test Results Risk.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2255595-remel-inc-recalls-yeastone-broth-11ml-10-box-used-in. Based on FDA recall #Z-0355-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0355-2027%22&limit=1).

The FDA announced on Oct. 19, 2026, that Remel, Inc. is recalling Yeastone Broth because it may report false susceptibility to antifungal agents. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Remel
  • Product: Yeastone Broth, 11ML, 10/BOX
  • Lot code: 440400
  • UDI-DI: 848838018817

The hazard

The affected lot did not meet specifications. The product may report false susceptibility to antifungal agents, specifically within the Azole family.

Context

GovInfoNow's records show Remel, Inc. has 23 other recalls on record since Nov. 2, 2017. Other recent recalls of similar products include Remel GC Agar Base Recall (June 3, 2026), Remel Yeastone Broth Recall (March 24, 2026), and Remel Campy CVA Medium 100/PK recall (Feb. 5, 2026). Other recent recalls of similar products include Remel Oxoid Agglutinating Sera Recall (March 25, 2026) and Medline Convenience Kits Recall (Aug. 11, 2026).

How to tell if you have this one

Check for the lot number 440400 on the Yeastone Broth packaging. The product is sold in 11ML vials, 10 per box, with UDI-DI 848838018817.

  • Brand
    Remel
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot

    Look for the lot number 440400 on the Yeastone Broth packaging.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 2 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “Worldwide - US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Massachusetts.

Recall timeline

FDA published this recall 23 days after the firm started it.

1. Firm started the recall: Oct 19, 202612. FDA classified it Class II: Nov 3, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0355-2027 (October 19, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0355-2027 to see it in context.
  • Plain-language summary written by qwen3:4b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA